| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/19/2006 | US20060015971 Commerical production of proteases in plants |
| 01/19/2006 | US20060015970 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 01/19/2006 | US20060015969 Novel immunoadhesins for treating and prventing toxicity and pathogen-mediated diseases |
| 01/19/2006 | US20060015967 Role in lignification and growth for plant phenylcoumaran benzylic ether reductase |
| 01/19/2006 | US20060015966 Transgenic plant cells and plants having modified activity of the GBSSI and of the BE protein |
| 01/19/2006 | US20060015965 Novel isoamylases and associated methods and products |
| 01/19/2006 | US20060015964 Soybean genes for resistance to aphis glycines |
| 01/19/2006 | US20060015962 Soybean cultivar 1000109 |
| 01/19/2006 | US20060015960 Production of heterologous proteins in avians |
| 01/19/2006 | US20060015958 Human artificial chromosome containing human antibody lambda light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission |
| 01/19/2006 | US20060015954 GPR54 knock-out mammals and screening methods using them |
| 01/19/2006 | US20060015950 Nuclear transfer embryo formation method |
| 01/19/2006 | US20060014942 Nucleotide sequences for the control of the expression of DNA sequences in a cell host |
| 01/19/2006 | US20060014936 Hybrid bacillus thuringiensis Cry1A/Cry1F DNA and plants and host cells transformed with same |
| 01/19/2006 | US20060014931 Novel promoter |
| 01/19/2006 | US20060014930 Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses |
| 01/19/2006 | US20060014760 Compounds and methods of use to treat infectious diseases |
| 01/19/2006 | US20060014746 Heteroaryl substituted fused bicyclic heteroaryl compounds as GABAA receptor ligands |
| 01/19/2006 | US20060014715 Control of gene expression |
| 01/19/2006 | US20060014713 Immunostimulatory oligonucleotide multimers |
| 01/19/2006 | US20060014711 Methods for modulating expression of exogenous genes in mammalian systems, and products related thereto |
| 01/19/2006 | US20060014695 Hpma-polyamine conjugates and uses therefore |
| 01/19/2006 | US20060014688 Methods of inhibiting tumor cell proliferation |
| 01/19/2006 | US20060014687 Bone delivery conjugates and method of using same to target proteins to bone |
| 01/19/2006 | US20060014686 Screening for agents that modulate the activity or expression of FOXM1; determining whether a subject has lung, colon, or breast cancer |
| 01/19/2006 | US20060014683 Procoagulant protein comprising polypeptide with amino acid substitutions; resistant to activated protein C; von Willebrand factor binding site deleted and thrombin cleavage site is mutated; treating hemophilia |
| 01/19/2006 | US20060014679 Drug screening; diabetes, obesity, hyperlipemia, arteriosclerosis, hypertension, cardiovascular disorders |
| 01/19/2006 | US20060014673 Kappa-A conopeptides and uses therefor |
| 01/19/2006 | US20060014669 Method for treating cancer and increasing hematocrit levels |
| 01/19/2006 | US20060014291 L-rhamnose-inducible expression systems |
| 01/19/2006 | US20060014290 Reducing or inhibiting a biofilm by modulating expression of a cysB gene present in a Gram-negative bacteria cell capable of biofilm formation; reducing infections |
| 01/19/2006 | US20060014289 Methods and compositions for enhancing delivery of double-stranded RNA or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells |
| 01/19/2006 | US20060014288 Nerve regeneration |
| 01/19/2006 | US20060014287 Propagating myogenic progenitor cells for use in treatment of muscle disorders; tissue repair; tissue targeted therapy |
| 01/19/2006 | US20060014286 Ligand-controlled regulation of endogenous gene expression |
| 01/19/2006 | US20060014278 Method for programmed differentiation of stem cells |
| 01/19/2006 | US20060014277 Novel human kielin-like proteins and polynucleotides encoding the same |
| 01/19/2006 | US20060014276 Chimeric adenoviruses |
| 01/19/2006 | US20060014265 Mutant alpha-amylases |
| 01/19/2006 | US20060014263 Extraction and purification of phosphodiesterase |
| 01/19/2006 | US20060014262 Beta1,3-galactosyltransferase and DNA encoding the same |
| 01/19/2006 | US20060014259 Process for the preparation of L-amino acids with amplification of the zwf gene |
| 01/19/2006 | US20060014258 DNA coding for a protein which imparts L-homoserine resistance to Escherichia coli bacterium, and a method for producing L-amino acids |
| 01/19/2006 | US20060014257 RSF1010 derivative Mob' plasmid containing no antibiotic resistance gene, bacterium comprising the plasmid and method for producing useful metabolites |
| 01/19/2006 | US20060014255 Methods for lyophilizing competent cells |
| 01/19/2006 | US20060014252 Flk-1 binding protein |
| 01/19/2006 | US20060014251 Alternatively spliced isoform of calcium channel, voltage dependent, alpha-II subunit (CACNA1I) |
| 01/19/2006 | US20060014250 Descendants of bacteria devoid of N terminal formylation useful for the production of proteins and peptides |
| 01/19/2006 | US20060014249 Human G-protein coupled receptor |
| 01/19/2006 | US20060014247 DNA constructs for obtaining in a filamentous fungus host (actinomycete) a higher production level of a carbohydrate degrading (CD) enzyme, having in its original state a catalytic module (CAT) and a carbohydrate binding module (CBM) separated by a linker region; Xylanase; use in paper industry |
| 01/19/2006 | US20060014243 Human G-protein chemokine receptor HSATU68 |
| 01/19/2006 | US20060014242 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
| 01/19/2006 | US20060014226 Nucleic acid and amino acid sequences of hemoglobin-response genes in Candida albicans and the use of reagents derived from these sequences in the diagnosis of disseminated Candida albicans infection |
| 01/19/2006 | US20060014222 Antibodies |
| 01/19/2006 | US20060014219 Method for measuring ion channel activity |
| 01/19/2006 | US20060014203 carbon nanotubes as electrodes; for biopolymers such as DNA and RNA |
| 01/19/2006 | US20060014202 production method of electrical connection structure and electric wiring; carbon nanotube as the electrode and contacting the electrode with the biopolymer (DNA, RNA, or a protein) then applying an electric current between the electrode and biopolymer |
| 01/19/2006 | US20060014199 Molecular detection of chromosome aberrations |
| 01/19/2006 | US20060014197 In vivo screening methods for identifying inhibitors of RNA polymerases |
| 01/19/2006 | US20060014188 System to detect inducible translocation |
| 01/19/2006 | US20060014184 Contacting a compound with a polypeptide having a specific amino acid sequence and measuring a compound-polypeptide property related to extra-cellular matrix (ECM) degradation, e.g., activation of a biological pathway producing a biochemical marker indicative of ECM degradation such as MMP1 |
| 01/19/2006 | US20060014182 Using hybrid RNA/DNA primer to replicate/propagate preferential messengegr RNA polynucleotides; gene expression analysis and drug discovery |
| 01/19/2006 | US20060014180 Human phosphatase RET31, and variants thereof |
| 01/19/2006 | US20060014179 Inferring function from shotgun sequencing data |
| 01/19/2006 | US20060014177 A sample storage substrate comprising an elastomeric substrate made of open cell foam, closed cell foam, or a combination thereof and a biological sample absorbed by the elastomeric substrate; resists degradation |
| 01/19/2006 | US20060014175 Functionalized fluorescent nanocrystal detection system |
| 01/19/2006 | US20060014172 Aptamer-nanoparticle conjugates and method of use for target analyte detection |
| 01/19/2006 | US20060014170 Detection without amplification and interference; measuring efficacy; packaged array can be used in robotic assembly for automated analysis |
| 01/19/2006 | US20060014169 Methods for obtaining directionally truncated polypeptides |
| 01/19/2006 | US20060014166 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of endometriosis |
| 01/19/2006 | US20060014156 Nucleic acid detecting or quantifying processes |
| 01/19/2006 | US20060014149 Methods for rolling circle amplification and signal trapping of libraries |
| 01/19/2006 | US20060014146 Method of creating a library of bacterial clones with varying levels of gene expression |
| 01/19/2006 | US20060014143 Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis |
| 01/19/2006 | US20060014139 Which comprises three N-helices and at least two, but not three, of the three C-helices of the trimer-of-hairpin structure of HIV gp41; inhibits infection of cells; drug screening; gene therapy |
| 01/19/2006 | US20060014138 detecting the presence or absence of a humoral response to a tumor antigen selected from Eukaryotic Translation Initiation Factor 4Gamma 1 (eIF4G 1), Ribosomal Protein L22 (RPL22), Ribosomal Protein L 13A (RPL13A), and protein XP-373908; prostate cancer |
| 01/19/2006 | US20060013883 Poloxamer and poloxamine compositions for nucleic acid delivery |
| 01/19/2006 | US20060013882 Tri-block copolymers for nanosphere-based drug delivery |
| 01/19/2006 | US20060013832 Methods for treating HIV infected subjects |
| 01/19/2006 | US20060013831 adjuvant peptide and heterologous an antigen; human immunodeficiency virus (HIV)-related peptides; antigen is cholera toxin; fusion protein |
| 01/19/2006 | US20060013829 Nucleic acid segments; coding zones; genetic engineered cells |
| 01/19/2006 | US20060013826 Recombinant measles viruses expressing epitopes of antigens of RNA viruses - use for the preparation of vaccine compositions |
| 01/19/2006 | US20060013817 identification of genetic products that are expressed in association with a tumor and the nucleic acid coding therefor. The invention relates to the therapy and diagnosis of diseases in which said genetic products that are expressed in association with a tumor are expressed in an aberrant manner. |
| 01/19/2006 | US20060013805 Transgenic circulating endothelial cells |
| 01/19/2006 | US20060013803 Modified dendritic cells |
| 01/19/2006 | US20060013736 System, substrate plate and incubation device for conducting bioassays |
| 01/19/2006 | US20060013732 Methods and devices for removal of organic molecules from biological mixtures using anion exchange |
| 01/19/2006 | US20060011549 Solid compositions for selective adsorption from complex mixtures |
| 01/19/2006 | US20060011478 Integration of biochemical protocols in a continuous flow microfluidic device |
| 01/19/2006 | DE19744212B4 Verfahren zur Herstellung von Ergosterol und dessen Zwischenprodukten mittels rekombinanter Hefen A process for producing ergosterol and intermediate products thereof by means of recombinant yeasts |
| 01/19/2006 | DE10247755B4 Selektive, lokale Aktivierung von Mitgliedern der TNF-Rezeptorfamilie durch systemisch inaktive nicht-Antikörper-TNF-Liganden-Fusionsproteine Selective, local activation of members of the TNF receptor family by systemically inactive non-antibody-TNF-ligand fusion proteins |
| 01/19/2006 | DE102005008908A1 Novel polypeptide having biological activity of NAD- or NADP-dependent alcohol dehydrogenase, useful for producing compounds such as enantiomerically pure alcohols |
| 01/19/2006 | DE102004031177A1 Neue Geruchsstoffe bildende Genprodukte von Bacillus licheniformis und darauf aufbauende verbesserte biotechnologische Produktionsverfahren Forming new fragrances gene of Bacillus licheniformis, upon which improved biotechnological production |
| 01/19/2006 | DE102004027335A1 Sequenzen für die Synthese antibakteriell wirkender Polyketide Sequences for the synthesis of antibacterial polyketide |
| 01/19/2006 | DE102004025452A1 Vakzine enthaltend BVDV Vaccine containing BVDV |
| 01/19/2006 | DE10043470B4 Verfahren zur Identifizierung von zellspezifischen Proteinen A method for identifying cell-specific protein |
| 01/19/2006 | CA2573607A1 Plants having improved growth characteristics and method for making the same |
| 01/19/2006 | CA2573443A1 Plants having improved growth characteristics and method for making the same |
| 01/19/2006 | CA2573176A1 Nup98-hox fusions for expansion of hemopoietic stem cells |
| 01/19/2006 | CA2572881A1 Antigen binding proteins directed against scavenger receptor b1 that inhibit hcv replication |